Effect of Clarithromycin on the Pharmacokinetics of Cabergoline in Healthy Controls and in Patients With Parkinson’s Disease
Abstract.: Cabergoline is used in the treatment of Parkinson’s disease (PD). Clarithromycin is a potent inhibitor of CYP3A4 and P-glycoprotein and is often co-administered with cabergoline in usual clinical practice. We studied the effect of clarithromycin co-administration on the blood concentratio...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2006-01-01
|
| coleção: | Journal of Pharmacological Sciences |
| Acesso em linha: | http://www.sciencedirect.com/science/article/pii/S1347861319345396 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|